DAB1 and Alzheimer disease: For example, ε4 allele carriers have an increased prevalence of Alzheimer’s disease, and a deficiency in signaling transduction involving VLDLR/apoER2-Dab1 has been suggested as a mechanism involved in Alzheimer’s disease.